发明名称 NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIBITORS
摘要 The invention provides compounds of Formula (I):;;and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
申请公布号 US2015133428(A1) 申请公布日期 2015.05.14
申请号 US201414541343 申请日期 2014.11.14
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 Velaparthi Upender;Darne Chetan Padmakar;Liu Peiying;Wittman Mark D.;Pearce Bradley C.;Araujo Erika M. V.;Dasgupta Bireshwar;Nair Jalathi Surendran;Janakiraman Sakthi Kumaran;Rachamreddy Chandrasekhar Reddy;Rao Mettu Mallikarjuna;Karuppiah Arul Mozhi Selvan Subbiah;Reddy Bandreddy Subba;Nagalakshmi Pulicharla;Bora Rajesh Onkardas;Maheshwarappa Shilpa Holehatti;Kumaravel Selvakumar;Mullick Dibakar;Sistla Ramesh
分类号 C07D487/04;C07D487/10;C07D491/20;C07D491/147 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound according to Formula (I):or a pharmaceutically acceptable salt thereof, wherein: X is independently selected from O and NH; R1 is independently selected from carbocyclyl substituted with 1-5 R5, and heterocyclyl comprising carbon atoms and 1 to 3 heteroatoms selected from N, NR4, O, S, and substituted with 1-5 R5; R2 is independently selected from (i) alkyl optionally substituted with F, Cl, Br, ORb, CN, NRaRa, —C(═O)NRaRa, C2-6 alkenyl substituted with 0-5 Re, C2-6 alkynyl substituted with 0-5 Re, carbocyclyl substituted with 1-8 R7, and heterocyclyl comprising carbon atoms and 1 to 4 heteroatoms selected from N, NR6, O, S, and substituted with 1-8 R7, (ii) cycloalkyl substituted with 1-8 R7, and (iii) cycloheteroalkyl substituted with 1-8 R7; R3a, R3b, R3c, R3d, R3e and R3f are independently selected from H, CN, substituted with 1-3 R8, —C(═O)ORb, —C(═O)NRaRa, —C(═O)Rb, —NRaC(═O)Rb, —NRaC(═O)ORb, —(CH2)r-carbocyclyl substituted with 1-3 R8, and —(CH2)r-heterocyclyl substituted with 1-3 R8; alternatively, R3a and R3b, or R3c and R3d, or R3e and R3f, together with the carbon atom to which they are both attached form a spiral carbocyclic or heterocyclic ring comprising carbon atoms and 1 to 4 heteroatoms selected from N, O, S, each substituted with 1-5 R8; alternatively, R3a and R3c or R3b and R3d together form a heterocyclic ring comprising carbon atoms and 1 to 4 heteroatoms selected from N, O, S, and substituted with 1-5 R8; R4 is independently selected from H, C1-4 alkyl substituted with 0-3 Re, —(CH2)rCN, —(CH2)rORb, (CH2)rS(O)pRc, —(CH2)rC(═O)Rb, —(CH2)rNRaRa, —(CH2)rC(═O)NRaRa, —(CH2)r—NRaC(═O)Rb, —(CH2)rNRaC(═O)ORb, —(CH2)rOC(═O)NRaRa, —(CH2)rNRaC(═O)NRaRa, —(CH2)rC(═O)ORb, —(CH2)rS(O)2NRaRa, —(CH2)rNRaS(O)2NRaRa, —(CH2)rNRaS(O)2Rc, (CH2)r-carbocyclyl substituted with 0-3 Re, and —(CH2)r-heterocyclyl substituted with 0-3 Re; R5, at each occurrence, is independently selected from H, C1-4 alkyl substituted with 0-3 Re, F, Cl, Br, ═O, CN, NO2, —ORb, —(CH2)rCN, —(CH2)rORb, (CH2)rS(O)pRc, —(CH2)rC(═O)Rb, —(CH2)rNRaRa, —(CH2)rC(═O)NRaRa, —(CH2)rNRaC(═O)Rb, —(CH2)rNRaC(═O)ORb, —(CH2)rOC(═O)NRaRa, —(CH2)rNRaC(═O)NRaRa, —(CH2)rC(═O)ORb, —(CH2)rS(O)2NRaRa, —(CH2)rNRaS(O)2NRaRa, —(CH2)rNRaS(O)2Re, (CH2)r-carbocyclyl substituted with 0-3 Re, and —(CH2)r-heterocyclyl substituted with 0-3 Re; R6 is independently selected from H, —C(═O)Rb, —CO(═O)Rb, —S(O)pRc, C1-6 alkyl substituted with 0-5 Re, —(CH2)r—C3-6carbocyclyl substituted with 0-5 Re, and —(CH2)r-heterocyclyl substituted with 0-5 Re; R7, at each occurrence, is independently selected from H, F, Cl, Br, ═O, —(CRdRd)rCN, NO2, —(CRdRd)rORb, —S(O)pRc, —C(═O)Rb, —(CRdRd)rNRaRa, —(CRdRd)rC(═O)NRaRa, —NRaC(═O)Rb, —NRaC(═O)ORb, —OC(═O)NRaRa, —NRaC(═O)NRaRa, —(CRdRd)rC(═O)ORb, —S(O)2NRaRa, —NRaS(O)2NRaRa, —NRaS(O)2Rc, C1-6 alkyl substituted with 0-5 Re, —(CRdRd)r—C3-6carbocyclyl substituted with 0-5 Re, and —(CRdRd)r-heterocyclyl substituted with 0-5 Re; R8, at each occurrence, is independently selected from H, F, Cl, Br, CN, C1-6 alkyl substituted with 0-5 Re, C2-6 alkenyl, C2-6 alkynyl, —(CH2)r—C3-6 cycloalkyl substituted with 0-5 Re, —(CH2)r-aryl substituted with 0-5 Re, —(CH2)r-heterocyclyl substituted with 0-5 Re, CO2H, —(CH2)rORb, and —(CH2)rNRaRa; Ra, at each occurrence, is independently selected from H, CN, C1-6 alkyl substituted with 0-5 Re, C2-6 alkenyl substituted with 0-5 Re, C2-6 alkynyl substituted with 0-5 Re, —(CH2)r—C3-10carbocyclyl substituted with 0-5 Re, and —(CH2)r-heterocyclyl substituted with 0-5 Re; or Ra and Ra together with the nitrogen atom to which they are both attached form a heterocyclic ring substituted with 0-5 Re; Rb, at each occurrence, is independently selected from H, C1-6 alkyl substituted with 0-5 Re, C2-6 alkenyl substituted with 0-5 Re, C2-6 alkynyl substituted with 0-5 Re, —(CH2)r—C3-10carbocyclyl substituted with 0-5 Re, and —(CH2)r-heterocyclyl substituted with 0-5 Re; Rc, at each occurrence, is independently selected from C1-6 alkyl substituted with 0-5 Re, C2-6alkenyl substituted with 0-5 Re, C2-6alkynyl substituted with 0-5 Re, C3-6carbocyclyl, and heterocyclyl; Rd, at each occurrence, is independently selected from H and C1-4alkyl substituted with 0-5 Re; Re, at each occurrence, is independently selected from F, Cl, Br, CN, NO2, ═O, C1-6 alkyl substituted with 0-5 Rf, C2-6 alkenyl, C2-6 alkynyl, —(CH2)r—C3-6 cycloalkyl, —(CH2)r-aryl, —(CH2)r-heterocyclyl, CO2H, —(CH2)rORf, SRf, and —(CH2)rNRfRf; Rf, at each occurrence, is independently selected from H, C1-5 alkyl optionally substituted with F, Cl, Br, C3-6 cycloalkyl, and phenyl, or Rf and Rf together with the nitrogen atom to which they are both attached form a heterocyclic ring optionally substituted with C1-4alkyl; p, at each occurrence, is independently selected from zero, 1, and 2; and r, at each occurrence, is independently selected from zero, 1, 2, 3, and 4.
地址 Princeton NJ US